Thomas Marbury
8PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jul 11, 2025
Pharmacokinetics and Safety of Fezolinetant in Women with Hepatic or Renal Impairment.Megumi Iwai, Xuegong Wang, Melanie Patton
|Jul 26, 2024
Safety and tolerability of the protein C activator AB002 in end-stage renal disease patients on hemodialysis: a randomized phase 2 trial.Norah G Verbout, Christina U Lorentz, Brandon D Markway
|Jul 17, 2024
Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment.Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia
|Jun 06, 2024
Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects.Shawn Flanagan, Voon Ong, Thomas Marbury
|Oct 19, 2023
Venetoclax pharmacokinetics in participants with end-stage renal disease undergoing haemodialysis.Behnam Noorani, Rajeev M Menon, Xin Chen
|Aug 09, 2023
A phase I, open-label, single-dose study to evaluate the effect of hepatic impairment on the pharmacokinetics and safety of futibatinib.Ling Gao, Ikuo Yamamiya, Mark Pinti
Pageof 2
Frequent Collaborators
2 joint publications
Neeraj Gupta
2 joint publications
Michael J Hanley
2 joint publications
Meera Tugnait
2 joint publications
Karthik Venkatakrishnan
1 joint publications
Rajinder Bhardwaj
1 joint publications
Mary K Donohue
1 joint publications
Jennifer Madonia
1 joint publications
Beth Morris
1 joint publications
Kyle T Matschke
1 joint publications
Robert Croop
